1. Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy
2. Department of Oncology and Haematology, University of Milan, Milan, Italy
3. Breast Oncology Center, Dana-Farber Cancer Institute, Boston, MA, USA
4. Breast Oncology Program, Harvard Medical School, Boston, MA, USA